Recent News

• 06.11.2025 - Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions
• 06.05.2025 - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority
• 05.29.2025 - Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System
• 05.07.2025 - INSPIRA ART100 System Approved by Israel’s Largest Healthcare Provider for Use in Organ Transplant Patients
• 04.23.2025 - Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing

Recent Filings

• 06.11.2025 - EX-99.1 EX-99.1
• 06.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 06.05.2025 - EX-99.1 EX-99.1
• 06.05.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.30.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.30.2025 - EX-99.1 EX-99.1
• 05.29.2025 - EX-99.1 EX-99.1
• 05.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.27.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.27.2025 - EX-99.1 EX-99.1